Company / Revenue per Share
Evolent Health, Inc. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$4.35
FY2025
5-year range
$2.61 / $27.27
FY2021-FY2025
Trend
-84.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share has fluctuated over the past 10 years, ranging from $2.61 in FY2021 to $109.85 in FY2016.
Based on SEC 10-K filings.
4.35 in FY2025 with a 5-year CAGR of -18.3%.
Declined from $22.82 to $4.35 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +7.5%
- 5-Year CAGR
- -18.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share decreased 84.1% year-over-year.
- Peak revenue per share was recorded in FY2016.
- Lowest revenue per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.84 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.35 | -84.1% |
| FY2024 | $27.27 | +19.5% |
| FY2023 | $22.82 | +552.4% |
| FY2022 | $3.50 | +34.0% |
| FY2021 | $2.61 | -78.2% |
| FY2020 | $11.96 | +12.0% |
| FY2019 | $10.68 | -23.3% |
| FY2018 | $13.93 | +47.7% |
| FY2017 | $9.43 | -91.4% |
| FY2016 | $109.85 | +238.8% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026